Chinese Arteriosclerosis Series Evaluation-She Minority Study
Condition(s):Vascular DiseaseLast Updated:October 14, 2016Unknown status
Hide Studies Not Open or Pending
Condition(s):Vascular DiseaseLast Updated:October 14, 2016Unknown status
Condition(s):Vascular DiseaseLast Updated:May 10, 2016Completed
Condition(s):Colorectal CancerLast Updated:August 3, 2022Recruiting
Condition(s):Effect of Drug; Toxicity, Drug; Secondary ResistanceLast Updated:March 15, 2022Completed
Condition(s):Osteosarcoma Metastatic; Pulmonary Disease; Resectable Sarcoma; SurvivalLast Updated:December 4, 2020Completed
Condition(s):Clinical Response; Histopathological Response; PrognosisLast Updated:April 10, 2019Completed
Condition(s):Effect of Drug; Toxicity, DrugLast Updated:July 16, 2021Recruiting
Condition(s):Effect of Drugs; Progression; Pediatric CancerLast Updated:May 19, 2020Withdrawn
Condition(s):Efficacy; ToxicityLast Updated:April 10, 2018Completed
Condition(s):Soft Tissue Sarcoma Adult; Advanced CancerLast Updated:May 19, 2020Withdrawn
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.